Was the move higher overdone?...The headwinds for the pharma industry…Harvard vs. The Administration 5/7/25
About this episode
Is the rally overdone? HSBC says yes. We’ll speak to the company’s chief of multi-asset strategy. Plus, the pharma is facing lots of headwinds on several fronts. We’ll speak with the CEO of Teva about how the industry can respond and get through it. And, an interview with the Education Secretary, Linda McMahon about the administration’s battle with Harvard.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time CNBC’s “Money Movers” publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from CNBC’s “Money Movers”
Bridgewater Founder Ray Dalio, Setup for Tech Earnings, Calls for DHS Funding Gr...
CNBC’s “Money Movers”
DOJ Drops Probe into Fed Chair Powell, OpenAI CFO Sarah Friar, CrowdStrike CEO o...
CNBC’s “Money Movers”
Software Tumbles, Chips Jump, Data Center Opportunity with CBRE CEO, Pinnacle Fi...
CNBC’s “Money Movers”
GE Vernona & AI Demand, Philip Morris CEO, SpaceX’s AI Strategy 4/22/26
CNBC’s “Money Movers”